China’s Head Start Explained
10:27–10:58 · 30s
A concise comparison of China’s investigator-initiated trials that skip early approvals, enabling Phase II data before India even begins testing—and attracting billion-dollar deals.
10:27–10:58 · 30s
A concise comparison of China’s investigator-initiated trials that skip early approvals, enabling Phase II data before India even begins testing—and attracting billion-dollar deals.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.